An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company. . . . → Read More: AI-Designed Antibodies for Start-Up Sought in Open Call
|
|||||
       
  |
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe. . . . → Read More: European Life Science Venture Fund Raises €472M  One comment - (Comments are closed)  Finance  biomedical, biotechnology, entrepreneurs, equity, Europe, investment, life sciences, medical device, pharmaceuticals, venture capital 
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, Europe, genomics, investment, licensing, life sciences, pharmaceuticals 
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M One comment - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, psychiatric, university, venture capital 
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger. . . . → Read More: Synthetic Antibody Company Goes Public in $230M Merger Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, Europe, investment, IPO, merger, pharmaceuticals 
A charitable foundation began work today supporting research on human longevity, with the goal of increasing lifespans to more than 120 years. . . . → Read More: Foundation Plans $1B for Longevity Research One comment - (Comments are closed) Finance biomedical, computer science, engineering, Europe, grant, life sciences, mathematics, medical device, pharmaceuticals, physical sciences 
A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections. . . . → Read More: Trial Underway Testing Cancer Drug as Covid-19 Therapy Comments are closed New products biomedical, biotechnology, clinical trials, Covid-19, Europe, India, life sciences, pharmaceuticals 
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, cancer, Europe, genomics, life sciences, pharmaceuticals, preclinical, university 
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies Comments are closed Joint ventures/collaborations biomedical, biotechnology, chemistry, Europe, genomics, licensing, life sciences, pharmaceuticals, physical sciences 
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease. . . . → Read More: Trial Shows Synthetic Antibody Slows Cognitive Decline One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, clinical trials, Europe, life sciences, pharmaceuticals, physical sciences |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
